IL-4/IL-5 release inhibitors (Zambon)

N/A

Report date: 2025/03/20 20:00:06

NME

Base Information

Drug NameIL-4/IL-5 release inhibitors (Zambon)

Drug Alias NameIL-4/IL-5 release inhibitors (Fournier)interleukin-4/interleukin-5 release inhibitors (Fournier)interleukin-4/interleukin-5 release inhibitors (Zambon)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionIL-5 release inhibitorsIL-4 release inhibitors

TargetsUpdating

Therapy Area/IndicationsHypersensitivity

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryItaly

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesFournier Pharma Corp

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesZambon

Active IndicationsN/A

Inactive IndicationsHypersensitivity

Other Information

ATC CodeN/A